Testimonial UCB

‘In 2015 we engaged with EATRIS to support our experimental medicines activities by exploring the use of novel technologies that are outside the scope of our internal capabilities and knowledge, with the aim of enhancing the predictive value of proof-of-concept clinical studies.

With the support of the EATRIS team we were able to identify leading experts within the EATRIS network with whom we worked to develop a work plan for this highly technically challenging project, which will be executed in a multi-site setting that leverages each team’s specific expertise towards a common goal. We are grateful to the EATRIS team for leading the way in a very promising collaboration.’


Jay Tibbitts
Senior Director, DMPK Strategy Group